Post-pandemic consumer demand for AI-driven fitness, recovery, and personalized health solutions is propelling the global wellness market past $1.8 trillion, redefining how individuals track, optimize, and manage their daily well-being.

WHO data shows a 94% global reduction in populations at risk of trachoma since 2002, positioning the disease as the first infectious cause of blindness potentially eliminated worldwide by 2030.

As global aging accelerates, CareTech is shifting from fragmented solutions to integrated systems that redefine how societies deliver, finance, and scale care.

As GLP-1 therapies move from short-term metabolic treatment into long-term longevity use, the absence of continuous safety monitoring is emerging as one of the most critical—and commercially consequential—gaps in preventive medicine.

As workforces age across advanced economies, leading global employers are quietly redesigning jobs, skills, and care infrastructure—treating longevity not as a risk to manage, but as a strategic asset to deploy.

2026 Global Healthcare Crisis: 7 Policies Reshaping Long-Term Care & Digital Health Markets